Morningside Venture Investments Ltd, 10% Owner at Kezar Life Sciences, Inc. (KZR), sold 55,500 shares at $7.10 ($396K) on 2022-12-29, disclosed to the SEC on 2023-01-05.
Open-market sale of $396k KZR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.10 | 25,000 | $178K | 44.8% |
| 2 | $7.10 | 500 | $4K | 0.9% |
| 3 | $7.17 | 30,000 | $215K | 54.3% |
| Total | $7.14 avg | 55,500 | $396K | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |